Article

Scleral spacing procedure study to begin

The FDA has approved Refocus Group's request to begin phase II clinical trials of its scleral implants and scleral spacing procedure for the surgical treatment of presbyopia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
Related Content
(Image credit: Wills Eye Hospital) Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer
August 8th 2025

Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 8th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Navigate successful cataract surgery with refractive technology
August 8th 2025

Navigate successful cataract surgery with refractive technology

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
August 8th 2025

(EyePod) From idea to impact: Navigating ophthalmic innovation

(Image credit: Wilmer Eye Institute/Johns Hopkins Medicine)
August 8th 2025

Wilmer Eye Institute marks 100 years: honoring the past, shaping the future

ForSight Robotics completes $125M Series B funding to address global surgeon shortage
August 8th 2025

ForSight Robotics completes $125M Series B funding to address global surgeon shortage

© 2025 MJH Life Sciences

All rights reserved.